0 Commenti
0 condivisioni
212 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Bispecific T Cell Engager Therapeutics Market Applications in Hematological OncologyThe hematological oncology sector represents the primary application area for bispecific T cell engager therapeutics, leveraging the platform's ability to achieve deep responses in relapsed and refractory blood cancers. In multiple myeloma, BCMA-directed BiTE therapeutics have demonstrated remarkable efficacy in heavily pretreated patients, including those with prior exposure to CAR-T therapy,...0 Commenti 0 condivisioni 155 Views 0 Anteprima
-
Long-Acting Injectable Oncology Drug Market Size Expected to Grow Significantly During 2026–2032 Driven by Rising Demand for Advanced Cancer Therapeutics"Long-Acting Injectable Oncology Drug Market Summary: According to the latest report published by Data Bridge Market Research, the Long-Acting Injectable Oncology Drug Market The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period This...0 Commenti 0 condivisioni 474 Views 0 Anteprima
-
Mitogen-Activated Protein Kinase (MAPK) Inhibitors Therapeutics Market Report: Precision Oncology and Drug Pipeline Trends"According to the latest report published by Data Bridge Market Research, the Mitogen-Activated Protein Kinase (MAPK) Inhibitors Therapeutics Market The expected CAGR of mitogen-activated protein kinase (MAPK) inhibitors therapeutics market is tend to be around 6.60% in the mentioned forecast period. The market is valued at USD 61.4 billion in 2022, and it would grow upto USD...0 Commenti 0 condivisioni 160 Views 0 Anteprima
-
mRNA Cancer Vaccines Therapeutics Market Poised for Explosive Growth as Personalized Immunotherapy Revolutionizes OncologyThe global mRNA Cancer Vaccines Therapeutics Market is on an explosive growth trajectory, driven by the revolutionary potential of messenger RNA (mRNA) technology to transform cancer treatment through personalized immunotherapy. According to a comprehensive report by Wise Guy Reports, the market was valued at USD 3.6 billion in 2024. It is projected to grow from USD 4.3 billion in...0 Commenti 0 condivisioni 723 Views 0 Anteprima
-
Natural Killer (NK) Cell Therapeutics Market Size and Oncology Trends 2033The oncology landscape is shifting toward more sophisticated, "off-the-shelf" cellular interventions that leverage the body’s innate immune system. The Natural Killer (NK) Cell Therapeutics Market was valued at USD 504.09 million in 2024 and is projected to skyrocket to USD 9,839.77 million by 2032, growing at an extraordinary CAGR of 109.97% during the...0 Commenti 0 condivisioni 609 Views 0 Anteprima
-
Streptozocin Market Advances with Ongoing Oncology Research and Expanding Focus on Rare Cancer TherapeuticsAccording to the latest report published by Data Bridge Market Research, the Streptozocin Market The global streptozocin market size was valued at USD 159.40 million in 2025 and is expected to reach USD 232.83 million by 2033, at a CAGR of 4.85% during the forecast period This Streptozocin Market document encompasses several market aspects such as market estimates and forecasts,...0 Commenti 0 condivisioni 545 Views 0 Anteprima
-
Viral Infections to Autoimmunity: Diversifying Indications Expand the Natural Killer Cell Therapeutics Market Beyond Traditional OncologyThe natural killer (NK) cell therapeutics market is expanding beyond its oncology roots, with emerging applications in viral infections, autoimmunity, and even aging-related diseases. NK cells, known for their role in innate immunity, are particularly effective against viruses like HIV, hepatitis, and—more recently—SARS-CoV-2. In autoimmunity, they show potential to modulate...0 Commenti 0 condivisioni 1K Views 0 Anteprima
-
Cancer Biologics Market Advances with Growing Innovation in Targeted Therapies and Next-Generation BiopharmaceuticalsAccording to the latest report published by Data Bridge Market Research, the Cancer Biologics Market The global cancer biologics market size was valued at USD 122.55 billion in 2024 and is projected to reach USD 195.62 billion by 2032, with a CAGR of 6.02% during the forecast period of 2025 to 2032. An influential Cancer Biologics Market advertising report puts light on the types...0 Commenti 0 condivisioni 283 Views 0 Anteprima
-
Cancer Biologics Market Advances with Growing Innovation in Targeted Therapies and Next-Generation BiopharmaceuticalsAccording to the latest report published by Data Bridge Market Research, the Cancer Biologics Market The global cancer biologics market size was valued at USD 122.55 billion in 2024 and is projected to reach USD 195.62 billion by 2032, with a CAGR of 6.02% during the forecast period of 2025 to 2032. An influential Cancer Biologics Market advertising report puts light on the types...0 Commenti 0 condivisioni 274 Views 0 Anteprima
-
Crizotinib Drugs Market Growing at 6.7% CAGR Through 2034According to a new report from Intel Market Research, the global Crizotinib Drugs market was valued at USD 582.4 million in 2025 and is projected to reach USD 1,043.7 million by 2034, growing at a CAGR of 6.7% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of lung cancer, increasing adoption of molecular diagnostic testing for genetic...0 Commenti 0 condivisioni 826 Views 0 Anteprima
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Commenti 0 condivisioni 574 Views 0 Anteprima
-
How Are Targeted Cancer Therapies Driving Innovation in the Hormone-Refractory Oncology Drug Market?Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...0 Commenti 0 condivisioni 934 Views 0 Anteprima
-
Mantle Cell Lymphoma Therapeutics Market Set for Strong Growth Through 2034The global healthcare and oncology sectors are witnessing rapid advancements in cancer therapeutics, particularly in the treatment of rare and aggressive blood cancers such as mantle cell lymphoma (MCL). Increasing awareness regarding early diagnosis, advancements in targeted therapies, and growing investments in oncology research are significantly contributing to industry expansion. The rising...0 Commenti 0 condivisioni 495 Views 0 Anteprima
-
Polycythemia Vera Market Expands with Advancements in Targeted Therapies and Personalized Hematology CareAccording to the latest report published by Data Bridge Market Research, the Polycytomia Vera Market The global Polycytomia Vera market size was valued at USD 1.35 billion in 2025and is expected to reach USD 1.99 billion by 2033, at a CAGR of 5.00% during the forecast period The persuasive Polycytomia Vera Market report covers several topics including market trend analysis,...0 Commenti 0 condivisioni 142 Views 0 Anteprima
-
Radiation-Induced Dermatitis Drug Market Size and Revenue Forecast to 2032According to the latest report published by Data Bridge Market Research, the Radiation-Induced Dermatitis Drug Marke The global radiation-induced dermatitis drug market size was valued at USD 489.95 million in 2024 and is expected to reach USD 650.17 million by 2032, at a CAGR of 3.60% during the forecast period The market research studies of...0 Commenti 0 condivisioni 440 Views 0 Anteprima
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Commenti 0 condivisioni 637 Views 0 Anteprima
-
US Gemcitabine Market Growth Outlook, Industry Trends and Forecast Through 2034Gemcitabine is a widely used chemotherapy medication that plays a crucial role in the treatment of various cancers, including pancreatic, breast, ovarian, bladder, and non-small cell lung cancer. The increasing global burden of cancer, coupled with advancements in oncology treatment protocols, is driving demand for effective chemotherapeutic agents. Growing healthcare investments and improved...0 Commenti 0 condivisioni 489 Views 0 Anteprima
-
Uterine Carcinosarcoma Market Size and Revenue Forecast to 2033According to the latest report published by Data Bridge Market Research, the Uterine Carcinosarcoma Market The Uterine Carcinosarcoma Market was valued at USD 25.72 billion in 2025 and is projected to reach USD 42.56 billion by 2033, growing at a CAGR of 6.50% from 2026 to 2033. The market is witnessing steady growth driven by increasing incidence of rare and...0 Commenti 0 condivisioni 631 Views 0 Anteprima
Pagine in Evidenza
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek